Posted inGenetics
Breathing Lung-on-a-Chip from One Human Donor Advances Personalized Medicine
Air sacs in the lungs called alveoli are crucial for gas exchange and provide an important barrier against inhaled viruses…
Posted inBiotechnology
NIH instability grows with exit of neuro director, leaving half of institutes under interim leadership
The National Institutes of Health is adding another leader to its lengthy string of departures, this time in the form…
Posted inBiotechnology
COVID-19 Disrupts Healthcare Access for All Americans
The COVID-19 pandemic has fundamentally disrupted numerous facets of daily life worldwide, and perhaps nowhere is this more evident than…
Posted inBiotechnology
Enhancing Heart Drug Therapy for Frail Seniors
The rising prevalence of frailty among older adults has emerged as a significant concern in the context of cardiovascular health.…
Posted inBiotechnology
Eco-Friendly Geopolymer Concrete from Quarry Dust and Waste
In the pursuit of sustainable construction materials, researchers have turned their attention towards the integration of quarry dust and industrial…
Posted inBiotechnology
Exploring Extracellular Vesicles: Biology and Therapeutic Insights
Extracellular vesicles (EVs) are emerging as pivotal components in the biology of intercellular communication, garnering increasing attention from researchers and…
Posted inBiotechnology
Laser-Printed Metasurfaces Enable Advanced Light Conversion, Detection
In a groundbreaking development poised to revolutionize photonic technologies, a team of researchers has unveiled an innovative approach to nonlinear…
Posted inMedical Technology
Insilico, fresh off its Hong Kong IPO, pens potential $888M cancer R&D pact with Servier
Right on the heels of its IPO, Insilico Medicine is starting the year with an oncology discovery and development pact…
Posted inBiotechnology
Neuro biotech Nido closes after phase 2 study fails to move needle in rare disease
After five years, Nido Biosciences has reached the end of the road, closing its doors after its lead neurological disease…
Posted inBiotechnology
AbbVie, Gilead gift themselves clinical-stage cancer drugs via licensing deals
AbbVie and Gilead Sciences each used the holiday season to reward their pipelines with a new clinical-stage cancer drug. Zejing…